(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Zen binding is enhanced in the presence of Mad. (A) Schematic
representation of the 42 bp wild-type (wt-42) and mutant oligonucleotides that
eliminate the core Smad-(Sm-42) or Zen-(Zm-42) binding sites, and the 128 bp
DNA fragment from the Race enhancer used in electrophoretic mobility
shift assays (EMSAs) showing Medea-(blue circle), Mad-(blue ovals) and
Zen-(red ovals) binding sites. (B) DNA binding requires the core consensus
sites. 32P-labeled wild type (lanes 1-4) and mutant
oligonucleotides (Sm-42, lanes 5-8; Zm-42, lanes 9-12) were incubated with no
protein (lanes 1,5,9); and 100 ng Mad (lanes 2,6,10), 100 ng Medea (lanes
3,7,11) or 10 ng Zen (lanes 4,8,12). Mad and Medea produce a single complex of
bound probe, whereas Zen produces two complexes. The slower migrating Zen
complex could be due to a Zen/Zen/DNA complex. Mutant Sm-42 (or Zm-42)
eliminated the binding of Mad/Medea (or Zen) without affecting the binding of
Zen (or Mad/Medea). (C) 32P-labeled wild-type DNA fragments were
incubated with no protein (lanes 1 and 5), increasing amounts of Mad (1 ng, 2
ng, and 5 ng in lanes 2-4, respectively), increasing amounts of Zen (0.1 ng,
0.3 ng, and 1 ng in lanes 6-9, respectively) or increasing amounts of Zen in
the presence of 1 ng of Mad (lanes 10-13). The amounts of Zen in lanes 10-13
were the same as in lanes 6-9. More Zen complexes are shifted in lanes 10-13
compared with lanes 6-9. In lane 13, a supershifted complex (arrow) is visible
above the Zen complex (arrowhead) that may be due to the formation of a
Mad/Zen/DNA complex or a Zen/Zen/DNA complex. (D) Similar experiment as in C,
except that Zen-Del was used instead of wild-type Zen. The same amounts of
proteins were used as in C. Enhancement of Zen binding by Mad was not
observed.